Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Richard L Md Lindstrom

Director at Ocular Therapeutix, Inc (OCUL)

Purchase track record

Not enough history. Based on 1 purchase with a full 90 days of price history.

—
Avg. 90-day return-7.4%
vs. S&P 500-16.9%
Beat the market0%
Paper profit on buys−$7K
Total bought / sold$461K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Feb 24SEC OCULOcular Therapeutix, Inc Buy 60,229246,933 held (+32%) $7.66 $461K -1.6%
  • Buy

    Director Richard L Md Lindstrom bought $461K of OCUL at $7.66 — first open-market purchase in our records; raises the stake by 32%.